Ardelyx, Inc. Profile Avatar - Palmy Investing

Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which h…

Biotechnology
US, Waltham [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ardelyx, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ardelyx, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ardelyx, Inc..

End of ARDX's Analysis
CIK: 1437402 CUSIP: 039697107 ISIN: US0396971071 LEI: - UEI: -
Secondary Listings
ARDX has no secondary listings inside our databases.